Intrinsic Bioprobes, Inc.



	Accelerate drug development Proteomics technology

   Intrinsic Bioprobes, Inc. provides high-content protein analysis
   services, enabling novel biomarker and proteomic discoveries.
   IBI characterizes proteins quickly and in high throughput, reducing
   development time and cutting bottom-line expenses.



		News Intrinsic Bioprobes receives an NIH award to work on MS based approaches for diabetes biomarker discovery.



		Events IBI to present at the 2008 American Association for Cancer Research Annual meeting in San Diego, CA, April 12-16, 2008.



		Publications Investigation of human protein variants and their frequency in the general population Multiplexed mass spectrometric immunoassay in biomarker research: a novel approach to the determination of a myocardial infarct

Home | Sitemap | Directions | Literature